Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)

Zobair Younossi, Maria Stepanova, Kwang-Hyub Han, Young-Suk Lim, Youn-Jae Lee, Wan-Long Chuang, Jia-Horng Kao, Rong-Nan Chien, Ting-Tsung Chang, Cheng-Yuan Peng

研究成果: 期刊稿件文章同行評審

原文美式英語
頁(從 - 到)376-376
期刊Journal of Gastroenterology and Hepatology
31
出版狀態已出版 - 2016

引用此